394 related articles for article (PubMed ID: 15659235)
21. Possible involvement of protease-activated receptor-1 in the regulation of morphine-induced dopamine release and hyperlocomotion by the tissue plasminogen activator-plasmin system.
Ito M; Nagai T; Mizoguchi H; Fukakusa A; Nakanishi Y; Kamei H; Nabeshima T; Takuma K; Yamada K
J Neurochem; 2007 Jun; 101(5):1392-9. PubMed ID: 17286591
[TBL] [Abstract][Full Text] [Related]
22. The role of organic cation transporter-3 in methamphetamine disposition and its behavioral response in rats.
Nakayama H; Kitaichi K; Ito Y; Hashimoto K; Takagi K; Yokoi T; Takagi K; Ozaki N; Yamamoto T; Hasegawa T
Brain Res; 2007 Dec; 1184():260-9. PubMed ID: 17988657
[TBL] [Abstract][Full Text] [Related]
23. Tumor necrosis factor-alpha and its inducer inhibit morphine-induced rewarding effects and sensitization.
Niwa M; Nitta A; Yamada Y; Nakajima A; Saito K; Seishima M; Noda Y; Nabeshima T
Biol Psychiatry; 2007 Sep; 62(6):658-68. PubMed ID: 17217924
[TBL] [Abstract][Full Text] [Related]
24. Implication of activated astrocytes in the development of drug dependence: differences between methamphetamine and morphine.
Narita M; Suzuki M; Kuzumaki N; Miyatake M; Suzuki T
Ann N Y Acad Sci; 2008 Oct; 1141():96-104. PubMed ID: 18991953
[TBL] [Abstract][Full Text] [Related]
25. Role of microsomal epoxide hydrolase in methamphetamine-induced drug dependence in mice.
Shin EJ; Bing G; Chae JS; Kim TW; Bach JH; Park DH; Yamada K; Nabeshima T; Kim HC
J Neurosci Res; 2009 Dec; 87(16):3679-86. PubMed ID: 19598248
[TBL] [Abstract][Full Text] [Related]
26. Roles of the histaminergic neurotransmission on methamphetamine-induced locomotor sensitization and reward: a study of receptors gene knockout mice.
Takino N; Sakurai E; Kuramasu A; Okamura N; Yanai K
Int Rev Neurobiol; 2009; 85():109-16. PubMed ID: 19607964
[TBL] [Abstract][Full Text] [Related]
27. Co-administration of dextromethorphan with methamphetamine attenuates methamphetamine-induced rewarding and behavioral sensitization.
Yang PP; Huang EY; Yeh GC; Tao PL
J Biomed Sci; 2006 Sep; 13(5):695-702. PubMed ID: 16865411
[TBL] [Abstract][Full Text] [Related]
28. [Role of tissue plasminogen activator in the rewarding effect of nicotine].
Nagai T; Yamada K
Nihon Arukoru Yakubutsu Igakkai Zasshi; 2008 Jun; 43(3):151-7. PubMed ID: 18646640
[TBL] [Abstract][Full Text] [Related]
29. Dopamine D
Tu G; Ying L; Ye L; Zhao J; Liu N; Li J; Liu Y; Zhu M; Wu Y; Xiao B; Guo H; Guo F; Wang H; Zhang L; Zhang L
Biol Psychiatry; 2019 Dec; 86(11):820-835. PubMed ID: 31060803
[TBL] [Abstract][Full Text] [Related]
30. Neuronal dopamine transporter activity, density and methamphetamine inhibition are differentially altered in the nucleus accumbens and striatum with no changes in glycosylation in rats behaviorally sensitized to methamphetamine.
Bjorklund NL; Sorg BA; Schenk JO
Synapse; 2008 Oct; 62(10):736-45. PubMed ID: 18651643
[TBL] [Abstract][Full Text] [Related]
31. The antibiotic minocycline prevents methamphetamine-induced rewarding effects in mice.
Fujita Y; Kunitachi S; Iyo M; Hashimoto K
Pharmacol Biochem Behav; 2012 Apr; 101(2):303-6. PubMed ID: 22260872
[TBL] [Abstract][Full Text] [Related]
32. Possible involvement of type 1 inositol 1,4,5-trisphosphate receptors up-regulated by dopamine D1 and D2 receptors in mouse nucleus accumbens neurons in the development of methamphetamine-induced place preference.
Kurokawa K; Mizuno K; Ohkuma S
Neuroscience; 2012 Dec; 227():22-9. PubMed ID: 23000618
[TBL] [Abstract][Full Text] [Related]
33. Thioredoxin-1 downregulation in the nucleus accumbens promotes methamphetamine-primed reinstatement in mice.
Huang M; Yan C; Yang X; Zhou X; Lv W; Guo N; Li Y; Bai J
Neuropharmacology; 2018 Sep; 139():117-123. PubMed ID: 29981334
[TBL] [Abstract][Full Text] [Related]
34. Involvement of glial cell line-derived neurotrophic factor in inhibitory effects of a hydrophobic dipeptide Leu-Ile on morphine-induced sensitization and rewarding effects.
Niwa M; Nitta A; Shen L; Noda Y; Nabeshima T
Behav Brain Res; 2007 Apr; 179(1):167-71. PubMed ID: 17331595
[TBL] [Abstract][Full Text] [Related]
35. Reinforcing effects of morphine are reduced in tissue plasminogen activator-knockout mice.
Yan Y; Yamada K; Mizoguchi H; Noda Y; Nagai T; Nitta A; Nabeshima T
Neuroscience; 2007 Apr; 146(1):50-9. PubMed ID: 17317018
[TBL] [Abstract][Full Text] [Related]
36. Long-lasting change in brain dynamics induced by methamphetamine: enhancement of protein kinase C-dependent astrocytic response and behavioral sensitization.
Narita M; Miyatake M; Shibasaki M; Tsuda M; Koizumi S; Narita M; Yajima Y; Inoue K; Suzuki T
J Neurochem; 2005 Jun; 93(6):1383-92. PubMed ID: 15935054
[TBL] [Abstract][Full Text] [Related]
37. Drug dependence, synaptic plasticity, and tissue plasminogen activator.
Yamada K; Nagai T; Nabeshima T
J Pharmacol Sci; 2005 Feb; 97(2):157-61. PubMed ID: 15684570
[TBL] [Abstract][Full Text] [Related]
38. Methamphetamine-induced hyperactivity and behavioral sensitization in PACAP deficient mice.
Fujii H; Ishihama T; Ago Y; Shintani N; Kakuda M; Hashimoto H; Baba A; Matsuda T
Peptides; 2007 Sep; 28(9):1674-9. PubMed ID: 17658665
[TBL] [Abstract][Full Text] [Related]
39. Methamphetamine-induced locomotor activity and behavioral sensitization: are dopamine d3 receptors involved?
Jones CD; Bartee JA; Leite-Browning ML; Blackshear MA
Cell Mol Biol (Noisy-le-grand); 2007 May; 53(4):15-22. PubMed ID: 17531156
[TBL] [Abstract][Full Text] [Related]
40. Attenuation by the 5-HT1A receptor agonist osemozotan of the behavioral effects of single and repeated methamphetamine in mice.
Ago Y; Nakamura S; Uda M; Kajii Y; Abe M; Baba A; Matsuda T
Neuropharmacology; 2006 Sep; 51(4):914-22. PubMed ID: 16863654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
